North America Medicinal Chemistry for Drug Discovery Market, By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), Design (Fragment-Based Variation, Structure-Based Drug Design, Diversity Oriented Synthesis, Chemogenomics, Natural Products and Others), Drug Type (Small Molecules and Biologics), Therapeutic Area (Oncology, Neurology, Infectious and Immune System Diseases, Cardiovascular Diseases, Digestive System Diseases and Others), End User (Contract Research Organization, Pharmaceuticals and Biotechnology Companies, Academic and Research Institutes and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2029.
Market Analysis and Insights: North America Medicinal Chemistry for Drug Discovery Market
North America medicinal chemistry for drug discovery market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 14.0% in the forecast period of 2022 to 2029 and is expected to reach USD 6,768.27 million by 2029. Rising demand for specialty medicines and surge-in lifestyle oriented diseases are the major drivers which propelled the demand of the market in the forecast period.
Medicinal chemistry for drug discovery comprises features such increasing need for safe and effective drugs will impact in launching new product by the manufactures into the market which enhance its demand as well as increase in research and development investment for discovery and development of novel drug molecules leads to the market growth. Currently various research studies are taking place which is expected to provide various other opportunities in the medicinal chemistry for drug discovery market. However, rise in cost of formulated drugs and stringent regulations expected to restraint the market growth in the forecast period.
The medicinal chemistry for drug discovery market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Medicinal Chemistry for Drug Discovery Market Scope and Market Size
Medicinal chemistry for drug discovery market is segmented on the based on the basis of process, design, drug type, therapeutic area, end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of process, the North America medicinal chemistry for drug discovery market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. In 2022, target selection segment is expected to dominate the market as it enhances the efficiency and effectiveness of the research and development process.
- On the basis of design, the North America medicinal chemistry for drug discovery market is segmented into fragment-based variation, structure-based drug design, diversity oriented synthesis, chemogenomics, natural products and others. In 2022, the fragment based variation segment is expected to dominate the market as it is widely used in biotech, pharma and academic institutions to identify large number of compounds under clinical trials and drugs necessitate to launch.
- On the basis of drug type, the North America medicinal chemistry for drug discovery market is segmented into small molecules and biologics. In 2022, small molecules segment is expected to dominate the market as these molecules exhibits higher specificity, potency and long duration of action.
- On the basis of therapeutic area, the North America medicinal chemistry for drug discovery market is segmented into oncology, infectious and immune system disease, neurology, cardiovascular disease, digestive system disease and others. In 2022, oncology segment is expected to dominate the market due to increasing prevalence of cancer and increase in research and development for discovery of advanced therapeutic molecule.
- On the basis of end user, the North America medicinal chemistry for drug discovery market is segmented into contract research organization, academic and research institutes, pharmaceutical & biotechnology companies and others. In 2022, contract research organization is expected to dominate in the market due to increasing number of CROs and increasing investment in pharmaceutical research and development to drive the CROs services.
Medicinal Chemistry for Drug Discovery Market Country Level Analysis
The medicinal chemistry for drug discovery market is analyzed and market size information is provided on the basis of process, design, drug type, therapeutic area and end user.
The countries covered in the medicinal chemistry for drug discovery market report are the U.S., Canada, and Mexico.
The U.S. is leading in the North America medicinal chemistry in drug discovery market due to increasing initiatives for research on rare diseases and orphan drugs and rising healthcare expenses. Canada is growing in North America medicinal chemistry in drug discovery market due to increasing clinical trial and research & Development for various chronic disease. Mexico is growing in North America medicinal chemistry in drug discovery market due to the increasing awareness towards developing treatment for chronic disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Advancements in Technology and Increase in Initiatives for Research on Rare and Orphan Drugs are boosting the Market Growth of Medicinal Chemistry for Drug Discovery
Medicinal chemistry for drug discovery market also provides you with detailed market analysis for every country growth in medicinal chemistry for drug discovery industry with medicinal chemistry for drug discovery sales, impact of advancement in the medicinal chemistry for drug discovery technology and changes in regulatory scenarios with their support for the medicinal chemistry for drug discovery market. The data is available for historic period 2011 to 2020.
Competitive Landscape and Medicinal Chemistry for Drug Discovery Market Share Analysis
Medicinal chemistry for drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to medicinal chemistry for drug discovery market.
Some major companies which are dealing in the medicinal chemistry for drug discovery market are Eurofins Scientific, Covance Inc. (now part of the LabCorp Group), WuXi Apptec, Charles River, Evotec SE, Piramal Pharma Solutions, Pfizer, Inc., Certara, USA, Sygnature Discovery Limited, Malvern Panalytical Ltd (Parent Company Spectris PLC), Jubilant Biosys Ltd. (A Jubilant Pharmova Limited Company), Taros Chemicals GmbH & Co. KG, Genscript Biotech Corporation, Nereid Therapeutics Inc., BioBlocks, Inc., Charnwood Molecular LTD, Domainex, Aurigene Pharmaceutical Services Ltd. (a subsidiary of Dr. Reddy’s Laboratories Ltd.), Selvita, Nanosyn, Drug Discovery Alliances Inc. among others.
Various market players provides with the latest technologies of medicinal chemistry for drug discovery which are also accelerating the medicinal chemistry for drug discovery market.
For instance,
- In February 2021, Selvita launched its new cell-based phenotypic assay platform for drug discovery. The platform launched is used to test new compounds having therapeutic potential in treatment of multiple diseases including fibrotic diseases, neuroinflammatory diseases among others. The platform launched enabled the company to generate more revenue from its portfolio of drug discovery services.
- In August 2020, Piramal Pharma Solutions collaborated with Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs. This integration program encompasses formulation development, drug substances, and drug product manufacturing. This collaboration enhanced the company’s existing portfolio for medicinal chemistry for drug discovery.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the medicinal chemistry for drug discovery which also provides the benefit for organization to improve their offering for Bronchiectasis.
SKU-
